«This way,» he says, «we can start to evaluate the use of various
compounds as biomarkers and indicators of patient recovery.»
Not exact matches
There are numerous services he says Linear could be selling to overseas clients such
as lab tests, assays, particular medical
compounding or a process that looks for a
biomarker, a signal in the blood that shows whether a certain drug being trialled is working or not.
«Our results, and methods, could have implications for the analysis of endogenous and exogeneous
compounds in the exhaled breath
as biomarkers of systemic and lung diseases,
as well
as in development of new approaches to study human exposure to airborne contamination.»
He completed his postdoctoral training from Columbia University where he later joined
as a research scientist to continue his work on identifying master regulators (MR) of various pathologies, developing methods for
biomarker discovery and understanding mechanism of action of
compounds.